Juno Therapeutics

Juno Therapeutics is a biotechnology company focused on developing advanced immunotherapy treatments for cancer. They engineer a patient’s own immune cells, called T-cells, to better recognize and attack cancer cells. By modifying these cells in a lab and then reintroducing them into the patient's body, Juno aims to create personalized, targeted therapies that can more effectively combat difficult cancers. Their approach represents a cutting-edge area of cancer treatment, leveraging the immune system’s power to improve outcomes and potentially offer fewer side effects than traditional therapies.